(Q37845823)

24 August 2017

1 reference

title

α-Synuclein in Parkinson disease and other neurodegenerative disorders (English)

1 reference

24 August 2017

1 reference

1 reference

1 reference

2

David R Williams

0 references

author name string

Michael Eller

series ordinal

1

1 reference

24 August 2017

language of work or name

1 reference

23 February 2011

1 reference

Clinical Chemistry and Laboratory Medicine

24 August 2017

published in

1 reference

24 August 2017

volume

49

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

403-408

1 reference

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Second consensus statement on the diagnosis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Multiple-system atrophy: a new alpha-synuclein disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Synucleinopathies: clinical and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Genomic and proteomic biomarkers for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Red blood cells are the major source of alpha-synuclein in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Determination of alpha-synuclein concentration in human plasma using ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Parkinson patient fibroblasts show increased alpha-synuclein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Biomarkers for cognitive impairment and dementia in elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.077

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.077

1 reference

24 August 2017

1 reference